Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 759

1.

Lung Inflammatory Environments Differentially Alter Mesenchymal Stromal Cell Behavior.

Abreu SC, Enes SR, Dearborn J, Goodwin M, Coffey A, Borg ZD, Dos Santos CC, Wargo MJ, Cruz FF, Loi R, DeSarno M, Ashikaga T, Antunes MA, Rocco PRM, Liu KD, Lee JW, Matthay MA, McKenna DH, Weiss DJ.

Am J Physiol Lung Cell Mol Physiol. 2019 Sep 25. doi: 10.1152/ajplung.00263.2019. [Epub ahead of print]

PMID:
31553626
2.

Clinically Relevant Model of Pneumococcal Pneumonia, ARDS, and Non-Pulmonary Organ Dysfunction in Mice.

Gotts JE, Bernard O, Chun L, Croze RH, Ross JT, Nesseler N, Wu X, Abbott J, Fang X, Calfee CS, Matthay MA.

Am J Physiol Lung Cell Mol Physiol. 2019 Sep 11. doi: 10.1152/ajplung.00132.2019. [Epub ahead of print]

PMID:
31509438
3.

Plasma total fibroblast growth factor 23 levels are associated with acute kidney injury and mortality in children with acute respiratory distress syndrome.

Hanudel MR, Zinter MS, Chen L, Gala K, Lim M, Guglielmo M, Deshmukh T, Vangala S, Matthay M, Sapru A.

PLoS One. 2019 Sep 5;14(9):e0222065. doi: 10.1371/journal.pone.0222065. eCollection 2019.

4.

Plasma sRAGE Acts as Genetically Regulated Causal Intermediate in Sepsis-Associated ARDS.

Jones TK, Feng R, Kerchberger VE, Reilly JP, Anderson BJ, Shashaty MGS, Wang F, Dunn TG, Riley TR, Abbott J, Ittner CAG, Christiani DC, Mikacenic C, Wurfel MM, Ware LB, Calfee CS, Matthay MA, Christie JD, Meyer NJ.

Am J Respir Crit Care Med. 2019 Sep 5. doi: 10.1164/rccm.201810-2033OC. [Epub ahead of print]

PMID:
31487195
5.

Therapeutic Effects of Hyaluronic Acid in Bacterial Pneumonia in the Ex Vivo Perfused Human Lungs.

Liu A, Park JH, Zhang X, Sugita S, Naito Y, Lee JH, Kato H, Hao Q, Matthay MA, Lee JW.

Am J Respir Crit Care Med. 2019 Aug 7. doi: 10.1164/rccm.201812-2296OC. [Epub ahead of print]

PMID:
31390880
6.

Association of Elevated Plasma Interleukin-18 Level With Increased Mortality in a Clinical Trial of Statin Treatment for Acute Respiratory Distress Syndrome.

Rogers AJ, Guan J, Trtchounian A, Hunninghake GM, Kaimal R, Desai M, Kozikowski LA, DeSouza L, Mogan S, Liu KD, Matthay MA, Steingrub J, Wheeler A, Yoon JH, Nakahira K, Choi AM, Baron RM.

Crit Care Med. 2019 Aug;47(8):1089-1096. doi: 10.1097/CCM.0000000000003816.

PMID:
31206358
7.

The ex vivo human lung: research value for translational science.

Ross JT, Nesseler N, Lee JW, Ware LB, Matthay MA.

JCI Insight. 2019 Jun 6;4(11). pii: 128833. doi: 10.1172/jci.insight.128833. eCollection 2019 Jun 6. Review.

8.

A Multicenter Study of the Causes and Consequences of Optimistic Expectations About Prognosis by Surrogate Decision-Makers in ICUs.

White DB, Carson S, Anderson W, Steingrub J, Bird G, Curtis JR, Matthay M, Peterson M, Buddadhumaruk P, Shields AM, Ernecoff N, Shotsberger K, Weissfeld L, Chang CH, Pike F, Lo B, Hough CL.

Crit Care Med. 2019 Sep;47(9):1184-1193. doi: 10.1097/CCM.0000000000003807.

PMID:
31162200
9.

Pulmonary Dead Space Monitoring: Identifying Subjects With ARDS at Risk of Developing Right Ventricular Dysfunction.

Papolos AI, Schiller NB, Belzer A, Zhuo H, Gotts JE, Bibby D, Calfee CS, Matthay MA.

Respir Care. 2019 Sep;64(9):1101-1108. doi: 10.4187/respcare.06544. Epub 2019 May 28.

PMID:
31138736
10.

Pathogenesis of Acute Respiratory Distress Syndrome.

Huppert LA, Matthay MA, Ware LB.

Semin Respir Crit Care Med. 2019 Feb;40(1):31-39. doi: 10.1055/s-0039-1683996. Epub 2019 May 6.

PMID:
31060086
11.

A prospective investigation of interleukin-8 levels in pediatric acute respiratory failure and acute respiratory distress syndrome.

Flori H, Sapru A, Quasney MW, Gildengorin G, Curley MAQ, Matthay MA, Dahmer MK; BALI and RESTORE Study Investigators, Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network.

Crit Care. 2019 Apr 17;23(1):128. doi: 10.1186/s13054-019-2342-8.

12.

Clinician-Family Communication About Patients' Values and Preferences in Intensive Care Units.

Scheunemann LP, Ernecoff NC, Buddadhumaruk P, Carson SS, Hough CL, Curtis JR, Anderson WG, Steingrub J, Lo B, Matthay M, Arnold RM, White DB.

JAMA Intern Med. 2019 May 1;179(5):676-684. doi: 10.1001/jamainternmed.2019.0027.

PMID:
30933293
13.

Precision medicine for cell therapy in acute respiratory distress syndrome - Authors' reply.

Matthay MA, Zhuo H, Gotts JE, Liu KD, Calfee CS.

Lancet Respir Med. 2019 Apr;7(4):e14. doi: 10.1016/S2213-2600(19)30083-9. No abstract available.

PMID:
30926051
14.

The authors reply.

Fielding-Singh V, Matthay MA, Calfee CS.

Crit Care Med. 2019 Apr;47(4):e380-e381. doi: 10.1097/CCM.0000000000003666. No abstract available.

PMID:
30882446
15.

The authors reply.

Fielding-Singh V, Matthay MA, Calfee CS.

Crit Care Med. 2019 Apr;47(4):e375-e376. doi: 10.1097/CCM.0000000000003648. No abstract available.

PMID:
30882440
16.

Acute respiratory distress syndrome.

Matthay MA, Zemans RL, Zimmerman GA, Arabi YM, Beitler JR, Mercat A, Herridge M, Randolph AG, Calfee CS.

Nat Rev Dis Primers. 2019 Mar 14;5(1):18. doi: 10.1038/s41572-019-0069-0. Review.

17.

Is a Part Better than the Whole for Cell-based Therapy for Acute Respiratory Distress Syndrome?

Lee JW, Matthay MA.

Anesthesiology. 2019 May;130(5):683-685. doi: 10.1097/ALN.0000000000002653. No abstract available.

PMID:
30870157
18.

Heterogeneity in sepsis: new biological evidence with clinical applications.

Leligdowicz A, Matthay MA.

Crit Care. 2019 Mar 9;23(1):80. doi: 10.1186/s13054-019-2372-2. Review.

19.

Positive Cumulative Fluid Balance Is Associated With Mortality in Pediatric Acute Respiratory Distress Syndrome in the Setting of Acute Kidney Injury.

Zinter MS, Spicer AC, Liu KD, Orwoll BE, Alkhouli MF, Brakeman PR, Calfee CS, Matthay MA, Sapru A.

Pediatr Crit Care Med. 2019 Apr;20(4):323-331. doi: 10.1097/PCC.0000000000001845.

PMID:
30672838
20.

ECMO in severe acute respiratory distress syndrome.

Matthay MA.

Lancet Respir Med. 2019 Feb;7(2):106-108. doi: 10.1016/S2213-2600(18)30507-1. Epub 2019 Jan 11. No abstract available.

PMID:
30642777
21.

Could Decisions to Limit Treatment Contribute to Mortality Differences between Patients with Different Presepsis Trajectories?

Block BL, Matthay M.

Ann Am Thorac Soc. 2019 Apr;16(4):522. doi: 10.1513/AnnalsATS.201810-680LE. No abstract available.

22.

Integrating host response and unbiased microbe detection for lower respiratory tract infection diagnosis in critically ill adults.

Langelier C, Kalantar KL, Moazed F, Wilson MR, Crawford ED, Deiss T, Belzer A, Bolourchi S, Caldera S, Fung M, Jauregui A, Malcolm K, Lyden A, Khan L, Vessel K, Quan J, Zinter M, Chiu CY, Chow ED, Wilson J, Miller S, Matthay MA, Pollard KS, Christenson S, Calfee CS, DeRisi JL.

Proc Natl Acad Sci U S A. 2018 Dec 26;115(52):E12353-E12362. doi: 10.1073/pnas.1809700115. Epub 2018 Nov 27.

23.

Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial.

Matthay MA, Calfee CS, Zhuo H, Thompson BT, Wilson JG, Levitt JE, Rogers AJ, Gotts JE, Wiener-Kronish JP, Bajwa EK, Donahoe MP, McVerry BJ, Ortiz LA, Exline M, Christman JW, Abbott J, Delucchi KL, Caballero L, McMillan M, McKenna DH, Liu KD.

Lancet Respir Med. 2019 Feb;7(2):154-162. doi: 10.1016/S2213-2600(18)30418-1. Epub 2018 Nov 16.

PMID:
30455077
24.

Prospective Assessment of the Feasibility of a Trial of Low-Tidal Volume Ventilation for Patients with Acute Respiratory Failure.

Lanspa MJ, Gong MN, Schoenfeld DA, Lee KT, Grissom CK, Hou PC, Serpa-Neto A, Brown SM, Iwashyna TJ, Yealy DM, Hough CL, Brower RG, Calfee CS, Hyzy RC, Matthay MA, Miller RR 3rd, Steingrub JS, Thompson BT, Miller CD, Clemmer TP, Hendey GW, Huang DT, Mathews KS, Qadir N, Tidswell M; The National Heart, Lung, and Blood Institute Prevention and Early Treatment of Acute Lung Injury (PETAL) Clinical Trials Network.

Ann Am Thorac Soc. 2019 Mar;16(3):356-362. doi: 10.1513/AnnalsATS.201807-459OC.

PMID:
30407869
25.

The Continued Need for Clinical Trials in Deceased Organ Donor Management.

Niemann CU, Matthay MA, Ware LB.

Transplantation. 2019 Jul;103(7):1298-1299. doi: 10.1097/TP.0000000000002512. No abstract available.

PMID:
30399123
26.

Therapeutic potential of mesenchymal stromal cells in the treatment of ARDS.

Huppert LA, Liu KD, Matthay MA.

Transfusion. 2019 Feb;59(S1):869-875. doi: 10.1111/trf.14835. Epub 2018 Nov 1. No abstract available.

PMID:
30383290
27.

AIMing Immunomodulation Therapy at Sepsis.

Leligdowicz A, Matthay MA.

Am J Respir Cell Mol Biol. 2019 Mar;60(3):253-254. doi: 10.1165/rcmb.2018-0338ED. No abstract available.

PMID:
30365342
28.

Plasma angiopoietin-2 as a potential causal marker in sepsis-associated ARDS development: evidence from Mendelian randomization and mediation analysis.

Reilly JP, Wang F, Jones TK, Palakshappa JA, Anderson BJ, Shashaty MGS, Dunn TG, Johansson ED, Riley TR, Lim B, Abbott J, Ittner CAG, Cantu E, Lin X, Mikacenic C, Wurfel MM, Christiani DC, Calfee CS, Matthay MA, Christie JD, Feng R, Meyer NJ.

Intensive Care Med. 2018 Nov;44(11):1849-1858. doi: 10.1007/s00134-018-5328-0. Epub 2018 Oct 21.

PMID:
30343317
29.

Identification of Acute Kidney Injury Subphenotypes with Differing Molecular Signatures and Responses to Vasopressin Therapy.

Bhatraju PK, Zelnick LR, Herting J, Katz R, Mikacenic C, Kosamo S, Morrell ED, Robinson-Cohen C, Calfee CS, Christie JD, Liu KD, Matthay MA, Hahn WO, Dmyterko V, Slivinski NSJ, Russell JA, Walley KR, Christiani DC, Liles WC, Himmelfarb J, Wurfel MM.

Am J Respir Crit Care Med. 2019 Apr 1;199(7):863-872. doi: 10.1164/rccm.201807-1346OC.

PMID:
30334632
30.

Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study.

Sinha P, Delucchi KL, Thompson BT, McAuley DF, Matthay MA, Calfee CS; NHLBI ARDS Network.

Intensive Care Med. 2018 Nov;44(11):1859-1869. doi: 10.1007/s00134-018-5378-3. Epub 2018 Oct 5.

PMID:
30291376
31.

Variability in Pediatric Ideal Body Weight Calculation: Implications for Lung-Protective Mechanical Ventilation Strategies in Pediatric Acute Respiratory Distress Syndrome.

Ward SL, Quinn CM, Steurer MA, Liu KD, Flori HR, Matthay MA.

Pediatr Crit Care Med. 2018 Dec;19(12):e643-e652. doi: 10.1097/PCC.0000000000001740.

PMID:
30277896
32.

Beyond Low Tidal Volume Ventilation: Treatment Adjuncts for Severe Respiratory Failure in Acute Respiratory Distress Syndrome.

Fielding-Singh V, Matthay MA, Calfee CS.

Crit Care Med. 2018 Nov;46(11):1820-1831. doi: 10.1097/CCM.0000000000003406. Review.

PMID:
30247273
33.

Pulmonary mechanics and gas exchange characteristics in uncommon etiologies of acute respiratory distress syndrome.

Kallet RH, Ho K, Lipnick MS, Matthay MA.

J Thorac Dis. 2018 Aug;10(8):5030-5038. doi: 10.21037/jtd.2018.07.78.

34.

Physiologic Analysis and Clinical Performance of the Ventilatory Ratio in Acute Respiratory Distress Syndrome.

Sinha P, Calfee CS, Beitler JR, Soni N, Ho K, Matthay MA, Kallet RH.

Am J Respir Crit Care Med. 2019 Feb 1;199(3):333-341. doi: 10.1164/rccm.201804-0692OC.

PMID:
30211618
35.

Meta-Analysis of Preclinical Studies of Fibrinolytic Therapy for Acute Lung Injury.

Liu C, Ma Y, Su Z, Zhao R, Zhao X, Nie HG, Xu P, Zhu L, Zhang M, Li X, Zhang X, Matthay MA, Ji HL.

Front Immunol. 2018 Aug 20;9:1898. doi: 10.3389/fimmu.2018.01898. eCollection 2018.

36.

Assessment of industry data on pulmonary and immunosuppressive effects of IQOS.

Moazed F, Chun L, Matthay MA, Calfee CS, Gotts J.

Tob Control. 2018 Nov;27(Suppl 1):s20-s25. doi: 10.1136/tobaccocontrol-2018-054296. Epub 2018 Aug 29.

37.

Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome.

Mi MY, Matthay MA, Morris AH.

N Engl J Med. 2018 Aug 30;379(9):884-887. doi: 10.1056/NEJMclde1804601. No abstract available.

PMID:
30157406
38.

Effects of bone marrow-derived mesenchymal stromal cells on gene expression in human alveolar type II cells exposed to TNF-α, IL-1β, and IFN-γ.

Schwede M, Wilfong EM, Zemans RL, Lee PJ, Dos Santos C, Fang X, Matthay MA.

Physiol Rep. 2018 Aug;6(16):e13831. doi: 10.14814/phy2.13831.

39.

Possible hepatotoxicity of IQOS.

Chun L, Moazed F, Matthay M, Calfee C, Gotts J.

Tob Control. 2018 Nov;27(Suppl 1):s39-s40. doi: 10.1136/tobaccocontrol-2018-054320. Epub 2018 Aug 21. No abstract available.

40.

Effect of Rosuvastatin on Acute Kidney Injury in Sepsis-Associated Acute Respiratory Distress Syndrome.

Hsu RK, Truwit JD, Matthay MA, Levitt JE, Thompson BT, Liu KD.

Can J Kidney Health Dis. 2018 Aug 2;5:2054358118789158. doi: 10.1177/2054358118789158. eCollection 2018.

41.

Early Plasma Matrix Metalloproteinase Profiles. A Novel Pathway in Pediatric Acute Respiratory Distress Syndrome.

Zinter MS, Delucchi KL, Kong MY, Orwoll BE, Spicer AS, Lim MJ, Alkhouli MF, Ratiu AE, McKenzie AV, McQuillen PS, Dvorak CC, Calfee CS, Matthay MA, Sapru A.

Am J Respir Crit Care Med. 2019 Jan 15;199(2):181-189. doi: 10.1164/rccm.201804-0678OC.

PMID:
30114376
42.

Interleukin-1 Receptor Antagonist Is Associated With Pediatric Acute Respiratory Distress Syndrome and Worse Outcomes in Children With Acute Respiratory Failure.

Dahmer MK, Quasney MW, Sapru A, Gildengorin G, Curley MAQ, Matthay MA, Flori H; BALI and RESTORE Study Investigators and Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network.

Pediatr Crit Care Med. 2018 Oct;19(10):930-938. doi: 10.1097/PCC.0000000000001680.

43.

Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial.

Calfee CS, Delucchi KL, Sinha P, Matthay MA, Hackett J, Shankar-Hari M, McDowell C, Laffey JG, O'Kane CM, McAuley DF; Irish Critical Care Trials Group.

Lancet Respir Med. 2018 Sep;6(9):691-698. doi: 10.1016/S2213-2600(18)30177-2. Epub 2018 Aug 2.

44.

Therapeutic effects of human mesenchymal stem cell microvesicles in an ex vivo perfused human lung injured with severe E. coli pneumonia.

Park J, Kim S, Lim H, Liu A, Hu S, Lee J, Zhuo H, Hao Q, Matthay MA, Lee JW.

Thorax. 2019 Jan;74(1):43-50. doi: 10.1136/thoraxjnl-2018-211576. Epub 2018 Aug 3.

45.

Low to Moderate Air Pollutant Exposure and Acute Respiratory Distress Syndrome after Severe Trauma.

Reilly JP, Zhao Z, Shashaty MGS, Koyama T, Christie JD, Lanken PN, Wang C, Balmes JR, Matthay MA, Calfee CS, Ware LB.

Am J Respir Crit Care Med. 2019 Jan 1;199(1):62-70. doi: 10.1164/rccm.201803-0435OC.

PMID:
30067389
46.

A psychometric study of the decisional conflict scale in surrogate decision makers.

Pecanac KE, Brown RL, Steingrub J, Anderson W, Matthay MA, White DB.

Patient Educ Couns. 2018 Nov;101(11):1957-1965. doi: 10.1016/j.pec.2018.07.006. Epub 2018 Jul 7.

PMID:
30054105
47.

Plasma sRAGE is independently associated with increased mortality in ARDS: a meta-analysis of individual patient data.

Jabaudon M, Blondonnet R, Pereira B, Cartin-Ceba R, Lichtenstern C, Mauri T, Determann RM, Drabek T, Hubmayr RD, Gajic O, Uhle F, Coppadoro A, Pesenti A, Schultz MJ, Ranieri MV, Brodska H, Mrozek S, Sapin V, Matthay MA, Constantin JM, Calfee CS.

Intensive Care Med. 2018 Sep;44(9):1388-1399. doi: 10.1007/s00134-018-5327-1. Epub 2018 Jul 26.

48.

Human pulmonary endothelial cell permeability after exposure to LPS-stimulated leukocyte supernatants derived from patients with early sepsis.

Leligdowicz A, Chun LF, Jauregui A, Vessel K, Liu KD, Calfee CS, Matthay MA.

Am J Physiol Lung Cell Mol Physiol. 2018 Nov 1;315(5):L638-L644. doi: 10.1152/ajplung.00286.2018. Epub 2018 Jul 19.

PMID:
30024307
49.

Expansion of hedgehog disrupts mesenchymal identity and induces emphysema phenotype.

Wang C, de Mochel NSR, Christenson SA, Cassandras M, Moon R, Brumwell AN, Byrnes LE, Li A, Yokosaki Y, Shan P, Sneddon JB, Jablons D, Lee PJ, Matthay MA, Chapman HA, Peng T.

J Clin Invest. 2018 Oct 1;128(10):4343-4358. doi: 10.1172/JCI99435. Epub 2018 Jul 12.

50.

Influence of Clinical Factors and Exclusion Criteria on Mortality in ARDS Observational Studies and Randomized Controlled Trials.

Pais FM, Sinha P, Liu KD, Matthay MA.

Respir Care. 2018 Aug;63(8):1060-1069. doi: 10.4187/respcare.06034. Epub 2018 Jul 10. Review.

Supplemental Content

Loading ...
Support Center